col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Publishing House: Mediar Press

26 Results       Page 1

 [1] 
  original article Journal Date Title Authors All Authors
1 [GO] Rheumatology Science and Practice 2023―Dec―27 Frequency and course of COVID-19 in patients with rheumatic diseases (according to the data of V.A. Nasonova Research Institute of Rheumatology) A. N. Kulikov, N. V. Muravyeva, B. S. Belov
2 [GO] Rheumatology Science and Practice 2023―Aug―31 Rheumatoid arthritis and COVID-19: Three years later B. S. Belov, E. S. Aronova, G. I. Gridneva, E. I. Nasonov
3 [GO] Rheumatology Science and Practice 2023―Mar―23 COVID-19 in a patient with granulomatosis with polyangiitis: Management tactics E. F. Iskhakova, E. V. Sukhorukova, M. Yu. Badeeva, E. V. Dyakova, S. A. Lapshina, T. V. Beketova, D. I. Abdulganieva
4 [GO] Rheumatology Science and Practice 2023―Mar―23 Multifocal osteonecrosis as a consequence of a new coronavirus infection A. A. Klimenko, N. A. Demidova, D. Yu. Andryashkina, N. M. Babadayeva, A. A. Kondrashov, Yu. M. Saakyan
5 [GO] Rheumatology Science and Practice 2023―Mar―23 Results of a 12-week open-label, non-interventional study of the efficacy and safety of olokizumab therapy in patients with rheumatoid arthritis after switching from anti-B-cell therapy during the SARS-CoV-2 pandemic A. A. Akimova, N. E. Banshchikova, A. E. Sizikov, A. A. Mullagaliev, E. A. Letyagina, N. A. Ilina, et al. (+6)
6 [GO] Rheumatology Science and Practice 2022―Dec―26 Avascular necrosis of the epiphyses of bones in patients who have had SARS-CoV-2 infection: Clinical observations and a narrative review of literature data V. E. Bialik, A. E. Karateev, E. I. Bialik, M. A. Makarov, S. A. Makarov, A. A. Roskidailo, et al. (+3)
7 [GO] Rheumatology Science and Practice 2022―Sep―08 COVID-19 in women with ankylosing spondylitis during pregnancy and within one year after childbirth O. A. Krichevskaya, T. V. Dubinina, E. V. Ilinykh, A. B. Demina, I. A. Andrianova
8 [GO] Rheumatology Science and Practice 2022―Jul―11 Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis Sh. F. Erdes
9 [GO] Rheumatology Science and Practice 2022―Jul―11 Autoantibodies and SARS-CoV-2 infection: A case report T. I. Kalenchic, S. L. Kabak, I. V. Korenevskaya
10 [GO] Rheumatology Science and Practice 2022―May―16 Interleukin 18 in Immune-mediated rheumatic diseases and COVID-19 E. L. Nasonov, A. S. Avdeeva
11 [GO] Rheumatology Science and Practice 2022―May―16 On the issue of post COVID-19 condition in patients with rheumatic diseases M. F. Beketova, V. V. Babak, M. D. Suprun, T. V. Beketova, O. A. Georginova
12 [GO] Rheumatology Science and Practice 2022―May―16 The use of biological disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis during the COVID-19 coronavirus disease pandemic: data from a telephone survey of 254 patients A. E. Karateev, E. Yu. Polishchuk, A. S. Potapova, E. V. Matyanova, A. S. Semashko, А. O. Bobkova, et al. (+5)
13 [GO] Rheumatology Science and Practice 2022―May―16 Effect of COVID-19 coronavirus infection on the course of rheumatoid arthritis V. N. Sorotskaya, A. O. Plakhova, B. B. Halmuradova, D. S. Vaisman, R. M. Balabanova
14 [GO] Rheumatology Science and Practice 2022―Mar―02 Vaccination against SARS-CoV-2 in rheumatic diseases: Safety issues B. S. Belov, A. M. Lila, E. L. Nasonov
15 [GO] Rheumatology Science and Practice 2021―Dec―27 Course and outcomes of COVID-19 in patients with immunoinflammatory rheumatic diseases: Preliminary data from the NIIR/APP-COVID-19 registry and literature review E. L. Nasonov, B. S. Belov, A. M. Lila, E. S. Aronova, G. I. Gridneva, A. V. Kudryavtseva, et al. (+5)
16 [GO] Rheumatology Science and Practice 2021―Dec―27 Anxiety, depression and stress tension screening in patients with rheumatic and musculoskeletal diseases at the onset of the 2019 coronavirus disease (COVID-19) pandemic A. B. Borisova, T. A. Lisitsyna, D. Yu. Veltishchev, E. L. Nasonov
17 [GO] Rheumatology Science and Practice 2021―Sep―06 B cell depletion in immune-mediated rheumatic diseases and coronavirus disease 2019 (COVID-19) E. L. Nasonov, A. S. Avdeeva
18 [GO] Rheumatology Science and Practice 2021―Jul―15 Coronavirus Disease 2019 (COVID-19) and Immune-mediated Rheumatic Diseases. Recommendations of the Association of Rheumatologists of Russia E. L. Nasonov, A. M. Lila, V. I. Mazurov, B. S. Belov, A. E. Karateev, T. V. Dubinina, et al. (+5)
19 [GO] Rheumatology Science and Practice 2021―May―13 Problems of early diagnosis of systemic lupus erythematosus during the COVID-19 pandemic E. L. Nasonov, T. V. Popkova, T. A. Panafidina
20 [GO] Rheumatology Science and Practice 2021―Mar―03 Coronavirus disease 2019 (COVID-19) and autoimmunity E. L. Nasonov
21 [GO] Rheumatology Science and Practice 2021―Mar―03 COVID-19 and rheumatology: A year later B. S. Belov, A. M. Lila
22 [GO] Rheumatology Science and Practice 2021―Mar―03 The course and outcomes of COVID-19 in patients with ANCA-associated systemic vasculitis, receiving biological therapy (Rituximab, Mepolizumab): The results of the first 8 months of the pandemic T. V. Beketova, V. V. Babak, M. D. Suprun
23 [GO] Rheumatology Science and Practice 2021―Jan―15 Remote monitoring of patients with axial spondyloarthritis during the COVID-19 pandemic: results and prospects of using the information technology “Aspine” D. G. Rumiantceva, A. M. Lila, Sh. Erdes
24 [GO] Rheumatology Science and Practice 2020―Nov―10 Coronavirus Desease 2019 (COVID-19) in Children: Lessons from Pediatric Rheumatology M. I. Kaleda, I. P. Nikishina, E. S. Fedorov, E. L. Nasonov
25 [GO] Rheumatology Science and Practice 2020―Sep―09 Coronavirus disease 2019 (COVID-19) and immune-mediated inflammatory rheumatic diseases: at the crossroads of thromboinflammation and autoimmunity E. L. Nasonov, T. V. Beketova, T. M. Reshetnyak, A. M. Lila, L. P. Ananieva, T. A. Lisitsyna, S. K. Soloviev
26 [GO] Rheumatology Science and Practice 2020―Sep―09 Covid-19 in a patient with ANCA-associated systemic vasculitis, receiving anti-B cell therapy (rituximab) T. V. Beketova, L. M. Blank, A. M. Lila
 [1] 

26 Results       Page 1




[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec